BRIEF published on 03/19/2024 at 10:05, 1 year ago ActiTrexx Initiates Treatment in Graft-versus-Host Disease Study with Novel T Cell Therapy Clinical Study ActiTrexx Graft-versus-Host Disease Regulatory T Cell Therapy Actileucel
PRESS RELEASE published on 03/19/2024 at 10:00, 1 year ago ActiTrexx treats first patient with novel regulatory T cell therapy against Graft-versus-Host Disease ActiTrexx GmbH treats first patient with novel regulatory T cell therapy for Graft-versus-Host Disease. Phase Ib/II study evaluates safety and feasibility of Actileucel treatment Graft-versus-Host Disease Regulatory T Cell Therapy Actileucel ActiTrexx GmbH Phase Ib/II Study
Published on 04/02/2025 at 15:00, 3 hours 18 minutes ago Doubleview Gold Corp 2025 Exploration Program
Published on 04/02/2025 at 14:00, 4 hours 18 minutes ago Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month
Published on 04/02/2025 at 14:00, 4 hours 18 minutes ago Avant Technologies Partner, Ainnova, to Sponsor and Present at 2025 Healthcare Innovation Summit in Mexico City
Published on 04/02/2025 at 17:59, 18 minutes ago Nagarro strengthens its SAP CX capabilities with the strategic business transfer of Notion Edge France
Published on 04/02/2025 at 17:51, 27 minutes ago Travis Perkins: TR1 Notification of Major Share Interest
Published on 04/02/2025 at 17:45, 32 minutes ago Endeavor Operating Company, LLC agrees to renew patent license agreement with the Kudelski Group
Published on 04/02/2025 at 17:35, 42 minutes ago Fuller, Smith & Turner PLC: Director / PDMR Shareholding
Published on 04/02/2025 at 17:45, 33 minutes ago Aéroports de Paris SA - Voting rights as of 31 March 2025
Published on 04/02/2025 at 17:45, 33 minutes ago Information concerning the total number of voting rights and shares 2025 03 31
Published on 04/01/2025 at 17:45, 1 day ago Covivio - Information on total number of voting rights and share capital
